|
![]() |
|||
|
||||
OverviewExplores topics from pharmacokinetics and tubulin targets to schedule dependence and clinical toxicity profiles. The book compiles current information on taxanes and their superior activity against small cell and non-small cell lung cancer that aims to enable researchers to optimize present and future palliative and curative strategies. Full Product DetailsAuthor: David Johnson (Vanderbilt University Med Ctr) , Jean KlasterskyPublisher: Taylor & Francis Inc Imprint: CRC Press Inc Dimensions: Width: 21.60cm , Height: 1.70cm , Length: 27.90cm Weight: 0.408kg ISBN: 9780824798925ISBN 10: 0824798929 Pages: 224 Publication Date: 01 April 1998 Audience: College/higher education , Professional and scholarly , Postgraduate, Research & Scholarly , Professional & Vocational Format: Hardback Publisher's Status: Out of Stock Indefinitely Availability: Out of stock ![]() Table of ContentsReviewsan excellent reference text for those interested in the use of taxanes in the treatment of lung cancer. -Clinical Oncology Author InformationTab Content 6Author Website:Countries AvailableAll regions |